Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

30.49 +0.21 (+0.69%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,974,032
Open 30.54
Bid (Size) 30.49 (3)
Ask (Size) 30.50 (3)
Prev. Close 30.28
Today's Range 30.20 - 30.94
52wk Range 23.15 - 129.39
Shares Outstanding 387,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Beaten-Down Stocks to Buy and Hold
Via The Motley Fool
Topics Death
Where Will Moderna Be in 10 Years?
Via The Motley Fool

Performance

YTD
-27.4%
-27.4%
1 Month
+11.8%
+11.8%
3 Month
+20.5%
+20.5%
6 Month
-27.7%
-27.7%
1 Year
-74.2%
-74.2%

More News

Read More
Why Moderna Stock Was So Healthy This Week
Via The Motley Fool
RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval
Via Benzinga
CDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory Panel
Via Stocktwits
Topics Government
Which S&P500 stocks are moving on Wednesday?
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
RFK Jr. Just Did The Unexpected. He Helped Moderna.
Via Investor's Business Daily
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Tuesday's session: top gainers and losers in the S&P500 index
Via Chartmill
Got $200? 2 Biotech Stocks to Buy and Hold Forever
Via The Motley Fool
Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?
Via Investor's Business Daily
Moderna's mRNA Flu Vaccine Outperforms Standard Shots
Via Benzinga
What's going on in today's pre-market session: S&P500 movers
Via Chartmill
Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial
Via Stocktwits
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
Via ACCESS Newswire
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm
Via Stocktwits
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group
Via Benzinga
Moderna, Pfizer, Novavax Draw Bearish Buzz Ahead Of CDC Panel With Vaccine Skeptics
Via Stocktwits
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
1 Volatile Stock with Impressive Fundamentals and 2 to Be Wary Of
Via StockStory
AI Meets Oncology: Caris Life Sciences' $5.35B IPO Tests Investor Appetite for Precision Medicine
Via Benzinga
Topics Artificial Intelligence Initial Public Offering
Robert F. Kennedy Jr.'s CDC Overhaul 'Critically Weakened' US Vaccine Program, Say Ousted Experts
Via Benzinga
Top S&P500 movers in Monday's session
Via Chartmill
Monday's session: top gainers and losers in the S&P500 index
Via Chartmill

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 30.49
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 07/03/25 01:00 PM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 11.80B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.